Last reviewed · How we verify
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
LAMIVUDINE, NEVIRAPINE, AND STAVUDINE is a drug developed by MACLEODS PHARMA. It is currently FDA-approved.
Lamivudine, nevirapine, and stavudine are antiretroviral medications used to treat HIV infections and AIDS. They are often used in combination with other medications, such as rifabutin, to treat co-infections like tuberculosis.
At a glance
| Generic name | LAMIVUDINE, NEVIRAPINE, AND STAVUDINE |
|---|---|
| Sponsor | MACLEODS PHARMA |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Pharmacokinetic Interaction Between Coartem® and Either Nevirapine, Efavirenz or Rifampicin in HIV Positive Ugandan Patients (Phase 4)
- A Randomized Open Label Trial of HIV Protease Inhibitors for the Prevention of Malaria in HIV-Infected Children (Phase 3)
- Steady State Bioequivalence of Generic and Innovator Formulations of Stavudine, Lamivudine, and Nevirapine in HIV-infected Ugandan Adults (Phase 4)
- A Phase II/III Randomized, Open-Label Study of Combination Antiretroviral Regimens and Treatment-Switching Strategies in HIV-1-Infected Antiretroviral Naive Children Between 30 Days and 18 Years of Ag (Phase 2)
- Phase 2 Comparison of Low-Dose Naltrexone vs ARV Effectiveness in HIV+ Progression (Phase 2)
- Comparison of the Steady State Pharmacokinetics of Nevirapine, Stavudine Plus Lamivudine in HIV Positive Ugandan Patients Taking Triomune 40 With the Pharmacokinetics of the Originator Products. (Phase 4)
- "Safeguard the Household" - A Study of HIV Antiretroviral Therapy Treatment Strategies Appropriate for a Resource Poor Country (NA)
- A Randomized, Open-Label Study of the Long-Term Effectiveness of Three Initial Highly Active Antiretroviral Therapy (HAART) Strategies in HAART-Niave, HIV-Infected Persons (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- LAMIVUDINE, NEVIRAPINE, AND STAVUDINE CI brief — competitive landscape report
- LAMIVUDINE, NEVIRAPINE, AND STAVUDINE updates RSS · CI watch RSS
- MACLEODS PHARMA portfolio CI
Frequently asked questions about LAMIVUDINE, NEVIRAPINE, AND STAVUDINE
What is LAMIVUDINE, NEVIRAPINE, AND STAVUDINE?
Who makes LAMIVUDINE, NEVIRAPINE, AND STAVUDINE?
What development phase is LAMIVUDINE, NEVIRAPINE, AND STAVUDINE in?
Related
- Manufacturer: MACLEODS PHARMA — full pipeline
- Therapeutic area: All drugs in Other
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing